Biovalence Technologies
Biovalence Technologies is dedicated to saving lives through innovative solutions, including broad-spectrum and pandemic antivirals. Their mission focuses on endless possibilities in saving lives, exemplified by their work on inhibiting SARS-CoV-2 replication.
Industries
biotechnology
life-science
medical
Nr. of Employees
small (1-50)
Biovalence Technologies
Products
Antiviral candidate with demonstrated inhibition of SARS‑CoV‑2 replication
A preclinical antiviral compound reported to inhibit SARS‑CoV‑2 replication in laboratory assays; positioned as a therapeutic candidate for viral infections.
Antiviral candidate with demonstrated inhibition of SARS‑CoV‑2 replication
A preclinical antiviral compound reported to inhibit SARS‑CoV‑2 replication in laboratory assays; positioned as a therapeutic candidate for viral infections.
Expertise Areas
- Broad‑spectrum antiviral drug development
- Pandemic antiviral programs
- Preclinical antiviral testing and evaluation
- Antiviral product development and commercialization
Key Technologies
- In vitro viral replication assays
- Antiviral screening assays
- Preclinical efficacy evaluation
- Therapeutic candidate development workflows